Mirjam Dijkstra

Affiliatie UvA Other Academic Staff, Laboratory Specialized Diagnostics & Research

Specialization

Focus of research

Latest publications

Biomarker Analysis Provides Evidence for Host Response Homogeneity in Patients With COVID-19
van Amstel, R. B. E., Michels, E. H. A., Appelman, B., de Brabander, J., Smeele, P. J., van der Poll, T., Vlaar, A. P. J., van Vught, L. A., Bos, L. D. J., van Agtmael, M. A., Algera, A. G., van Baarle, F. E. H. P., van de Beek, D., Beudel, M., Bogaard, H. J., Botta, M., de Bree, G. J., Brouwer, M. C., de Bruin, S. & Bugiani, M. & 59 others, Bulle, E. B., Chouchane, O., Cloherty, A. P. M., Buis, D., de Rotte, M. C. F. J., Dijkstra, M., Dongelmans, D. A., Dujardin, R. W. G., Elbers, P. E., Fleuren, L. M., Geerlings, S. E., Geijtenbeek, T. B. H., Girbes, A. R. J., Goorhuis, B., Grobusch, M. P., Hagens, L. A., Hamann, J., Harris, V. C., Hemke, R., Hermans, S. M., Heunks, L. M. A., Hollmann, M. W., Horn, J., Hovius, J. W., de Jong, M. D., Koning, R., Lim, E. H. T., van Mourik, N., Nellen, J. F., Nossent, E. J., Paulus, F., Peters, E., Piña-Fuentes, D., Preckel, B., Raasveld, J., Reijnders, T. D. Y., Schinkel, M., Schrauwen, F. A. P., Schultz, M. J., Schuurman, A. R., Schuurmans, J., Sigaloff, K., Slim, M. A., Smeele, P., Smit, M. R., Stijnis, C., Stilma, W., Teunissen, C. E., Thoral, P., Tsonas, A. M., Tuinman, P. R., van der Valk, M., Veelo, D. P., Volleman, C., de Vries, H., van Vugt, M., Wiersinga, J., Wouters, D. & Zwinderman, K., 1 Jun 2024, In: CHEST Critical Care. 2, 2, 100062.
Research output: Contribution to journal › Article › Academic › peer-review
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
COVID-STORM Clinicians, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID Clinicians, NIAID-USUHS COVID Study Group, Orchestra Working Group & Pina-Fuentes, D. A. I., 1 Dec 2023, In: Genome medicine. 15, 1, p. 22 22.
Research output: Contribution to journal › Article › Academic › peer-review
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
the Amsterdam UMC COVID-19 Biobank Investigators, 1 Dec 2022, In: Respiratory research. 23, 1, 6 p., 375.
Research output: Contribution to journal › Article › Academic › peer-review
All publications

Mirjam Dijkstra

Specialization

Focus of research

Biomarker Analysis Provides Evidence for Host Response Homogeneity in Patients With COVID-19

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

Amsterdam UMC makes use of cookies